In silico studies and biological evaluation of thiosemicarbazones as cruzain-targeting trypanocidal agents for Chagas disease (2026)
- Authors:
- USP affiliated authors: ANDRICOPULO, RENATA KROGH - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; DÖRING, THIAGO HENRIQUE - IFSC
- Unidade: IFSC
- DOI: 10.3390/pharmaceutics18010065
- Subjects: DOENÇA DE CHAGAS; PLANEJAMENTO DE FÁRMACOS
- Keywords: ADMET; Chagas disease; Cruzain inhibition; Molecular docking; Thiosemicarbazones
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmaceutics
- ISSN: 1999-4923
- Volume/Número/Paginação/Ano: v. 18, n. 1, p. 65-1-65-14, Jan. 2026
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MEIER, Lidiane et al. In silico studies and biological evaluation of thiosemicarbazones as cruzain-targeting trypanocidal agents for Chagas disease. Pharmaceutics, v. 18, n. Ja 2026, p. 65-1-65-14, 2026Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics18010065. Acesso em: 25 jan. 2026. -
APA
Meier, L., Melo Milena F. C. V. de,, Abreu, H. R., Oliveira, I. M. de, Sens, L., Döring, T. H., et al. (2026). In silico studies and biological evaluation of thiosemicarbazones as cruzain-targeting trypanocidal agents for Chagas disease. Pharmaceutics, 18( Ja 2026), 65-1-65-14. doi:10.3390/pharmaceutics18010065 -
NLM
Meier L, Melo Milena F. C. V. de, Abreu HR, Oliveira IM de, Sens L, Döring TH, Krogh R, Beatriz A, Andricopulo AD, Saba S, Oliveira AS de, Rafique J. In silico studies and biological evaluation of thiosemicarbazones as cruzain-targeting trypanocidal agents for Chagas disease [Internet]. Pharmaceutics. 2026 ; 18( Ja 2026): 65-1-65-14.[citado 2026 jan. 25 ] Available from: https://doi.org/10.3390/pharmaceutics18010065 -
Vancouver
Meier L, Melo Milena F. C. V. de, Abreu HR, Oliveira IM de, Sens L, Döring TH, Krogh R, Beatriz A, Andricopulo AD, Saba S, Oliveira AS de, Rafique J. In silico studies and biological evaluation of thiosemicarbazones as cruzain-targeting trypanocidal agents for Chagas disease [Internet]. Pharmaceutics. 2026 ; 18( Ja 2026): 65-1-65-14.[citado 2026 jan. 25 ] Available from: https://doi.org/10.3390/pharmaceutics18010065 - Design, synthesis, and in vitro evaluation of 4-(arylchalcogenyl)methyl)-1H-1,2,3-triazol-1-yl-menadione: exploring their potential against tuberculosis
- Synthesis of the macrolactone of migrastatin and analogues with potent cell-migration inhibitory activity
- SAR studies on a series of reversible competitive inhibitors of cruzain from Trypanosoma cruzi
- Orbitides: a quite unusual class of biologically active small peptides in some plant species from brazilian biodiversity
- Multi parametric optimization of a series of potent cruzain inhibitors as drug candidates for chagas disease
- Síntese total das marinoquinolinas A, B, C e E e análogos não-naturais
- Synthesis, electrochemical studies and anticancer activity of ferrocenyl oxindoles
- Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons
- Linear peptide analogues from Jatropha's orbitides promote migration of human neonatal foreskin fibroblasts in vitro and collagen deposition
- Planejamento de novos agentes quimioterápicos para o tratamento da doença de Chagas
Informações sobre o DOI: 10.3390/pharmaceutics18010065 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
